Applied Therapeutics Azioni (NASDAQ: APLT)

Applied Therapeutics (NASDAQ:APLT) Azioni, Quote.MetaTitle.unusual-options

Applied Therapeutics

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics Inc

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Alpha Cognition

Agenus

Anixa Biosciences

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Climb Bio

Coya Therapeutics

Citius Oncology

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

EXoZymes

Fate Therapeutics

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

TuHURA Biosciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Opus Genetics

Seres Therapeutics

MDxHealth

Nkarta

Oncolytics Biotech

AVITA Medical

Spero Therapeutics

Vor Biopharma

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

Applied Therapeutics (APLT) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Comments

Applied Therapeutics Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO